SCHEMBL8469680

SCHEMBL8469680

CC(C)Oc1ccc(-c2cccc(O)c2)cc1

nearest known ligand 0.61

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HSD17B1 P14061 11/20 0.61
HSD17B2 P37059 10/20 0.61
CYP2C9 P11712 4/20 0.61
CYP3A4 P08684 3/20 0.61
RXRA P19793 1/20 0.55
RXRB P28702 1/20 0.55
ESR1 P03372 3/20 0.52
CYP1A2 P05177 2/20 0.52
CYP2C19 P33261 2/20 0.52
ESR2 Q92731 2/20 0.52
CYP2D6 P10635 1/20 0.52
CYP2B6 P20813 1/20 0.52
CYP17A1 P05093 1/20 0.49
PTPN5 P54829 1/20 0.47
GAA P10253 1/20 0.46
PKM P14618 1/20 0.46
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
FFAR4 Q5NUL3 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2095173 0.83 HSD17B1 (0.49) HSD17B1HSD17B2CYP2C9CYP3A4RXRA
SCHEMBL8189613 0.82 HSD17B1 (0.61) HSD17B1HSD17B2CYP2C9CYP3A4ESR1
SCHEMBL8524895 0.82 RXRA (0.69) HSD17B1HSD17B2CYP2C9CYP3A4RXRA
SCHEMBL863444 0.81 ESR2 (0.58) CYP2C9ESR1CYP1A2CYP2C19ESR2
SCHEMBL1026075 0.79 HSD17B1 (0.68) HSD17B1HSD17B2CYP2C9CYP3A4ESR1
SCHEMBL6002565 0.79 HSD17B1 (0.53) HSD17B1HSD17B2CYP2C9CYP3A4ESR1
SCHEMBL30398332 0.79 CYP3A4 (0.62) HSD17B1HSD17B2CYP3A4RXRARXRB
SCHEMBL105731 0.79 CYP3A4 (0.62) HSD17B1HSD17B2CYP3A4RXRARXRB
SCHEMBL4677364 0.79 HSD17B1 (0.74) HSD17B1HSD17B2CYP2C9CYP3A4ESR1
SCHEMBL2096774 0.79 RXRA (0.51) CYP2C9RXRARXRBCYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1999025707-A1 2-ARYLBENZO[b]THIOPHENES USEFUL FOR THE TREATMENT OF ESTROGEN DEPRIVATION SYNDROME ELI LILLY AND COMPANY (US) 1999-05-27 WO claimed